Fresenius SE & Co. (FSNUY) to Announce Quarterly Earnings on Wednesday

Posted by John Perry on Jul 29th, 2026

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) will likely be issuing its resultson Wednesday, August 5th. Analysts expect Fresenius SE & Co. to post earnings of $0.25 per share and revenue of $6.6540 billion for the quarter.

Fresenius SE & Co. (OTCMKTS:FSNUY – Get Free Report) last released its earnings results on Wednesday, May 6th. The company reported $0.24 EPS for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.01). Fresenius SE & Co. had a net margin of 6.55% and a return on equity of 10.09%. The business had revenue of $6.75 billion for the quarter, compared to the consensus estimate of $6.79 billion. On average, analysts expect Fresenius SE & Co. to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Fresenius SE & Co. Trading Up 0.5%

Shares of OTCMKTS FSNUY opened at $12.71 on Wednesday. The company has a debt-to-equity ratio of 0.41, a quick ratio of 0.98 and a current ratio of 1.27. The business’s 50 day moving average price is $11.55 and its 200-day moving average price is $12.84. Fresenius SE & Co. has a fifty-two week low of $10.33 and a fifty-two week high of $33.93. The company has a market cap of $28.63 billion, a price-to-earnings ratio of 16.95 and a beta of 0.63.

Analysts Set New Price Targets

Separately, Morgan Stanley reaffirmed an “overweight” rating on shares of Fresenius SE & Co. in a research report on Tuesday, July 21st. Three research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy”.

View Our Latest Report on Fresenius SE & Co.

Fresenius SE & Co. Company Profile

(Get Free Report)

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.